| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/07/1990 | EP0353565A1 Immunostimulating peptides, a process for their preparation and pharmaceutical commpositions containing them |
| 02/07/1990 | EP0353516A2 A method for the preparation of recombinant human beta interleukin-1 in the homogeneous form |
| 02/07/1990 | EP0353250A1 The engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins |
| 02/07/1990 | CN1039440A Tissue plasminogen activator analogue |
| 02/06/1990 | US4898931 Novel human interferon-γ polypeptide derivative |
| 02/06/1990 | US4898830 Glandular disorders; gene expression and construction |
| 02/06/1990 | US4898818 Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism |
| 02/06/1990 | US4898815 Diagnostic serum from rabbit treated with polypeptide kit to detect cholera or escherichia |
| 02/06/1990 | CA1265650A1 Method for purifying a physiologically active substance produced by recombinant dna technique |
| 02/06/1990 | CA1265649A1 Peptide antibodies and their use in detecting oncogene products |
| 02/06/1990 | CA1265648A1 Leukemia-associated virus immunogen, vaccine and assay |
| 02/06/1990 | CA1265461A1 Method for isolation of recombinant polypeptides in biologically active forms |
| 02/06/1990 | CA1265447A1 Hepatitis b antigenic compositions and vaccines against hepatitis b derived therefrom |
| 02/06/1990 | CA1265446A1 Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component |
| 02/06/1990 | CA1265445A1 Composition for use in treating inflammation |
| 02/06/1990 | CA1265444A1 Effect of human tumor necrosis factor and human interferon on human cancer cells and methods |
| 02/05/1990 | EP0272253A4 Method for enhancing glycoprotein stability. |
| 01/31/1990 | EP0353211A1 New compounds |
| 01/31/1990 | EP0353188A2 Novel expression system |
| 01/31/1990 | EP0353150A1 Recombinant non-glycosylated human IL2 in reduced form, process for its production and its medical use |
| 01/31/1990 | EP0353111A1 Nucleic acid or fragments thereof encoding the P30 protein of Toxoplasma gondii, methods for their preparation and uses thereof |
| 01/31/1990 | EP0352903A2 Bovine factor Xa inhibiting factor and pharmaceutical compositions containing the same |
| 01/31/1990 | EP0352894A2 Production of cosmetic or pharmaceutical composition |
| 01/31/1990 | EP0352839A2 Process for producing hEGF |
| 01/31/1990 | EP0352816A2 IL-1alpha derivates and medicament for treating thrombocytopenia |
| 01/31/1990 | EP0352761A2 Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use |
| 01/31/1990 | EP0352707A2 An expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces |
| 01/31/1990 | EP0352678A2 Method for separating and recovering proteins present in fluids by means of a rotary column |
| 01/31/1990 | EP0352651A1 Human protein C mutants and method for preparing the same |
| 01/31/1990 | EP0352646A2 FR901228 Substance and preparation thereof |
| 01/31/1990 | EP0352538A2 Amides of N15-alkyl and N15,N15-dialkyl teicoplanin derivatives |
| 01/31/1990 | EP0352387A1 Method for preparing a hirudin |
| 01/31/1990 | EP0352328A1 Human monoclonal antibody against aspergilli |
| 01/31/1990 | EP0135181B1 Process for the production of n-alkylated dipeptides and of their esters |
| 01/30/1990 | US4897471 Consensus human leukocyte interferon |
| 01/30/1990 | US4897464 Purified protein having angiogenic activity and methods of preparation |
| 01/30/1990 | US4897463 Glycine and glutamic acid hexapeptide |
| 01/30/1990 | US4897354 Monoclonal antibody-specific merozoite antigens |
| 01/30/1990 | US4897348 Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof |
| 01/30/1990 | US4897264 Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody |
| 01/30/1990 | CA1265136A1 Derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| 01/30/1990 | CA1265135A1 Hydrazide imide derivatives of indole-dihydroindole alkaloids |
| 01/30/1990 | CA1265054A1 Vaccine for generating an immunogenic t cell response protective against a virus |
| 01/30/1990 | CA1265051A1 Pasteurized, isoagglutinin-free factor viii preparation and a process for its production |
| 01/30/1990 | CA1265048A1 Protein which is characteristic of rheumatoid arthritis |
| 01/26/1990 | EP0362298A4 Novel polypeptide having gamma-interferon activity. |
| 01/25/1990 | WO1990000624A1 Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| 01/25/1990 | WO1990000617A1 Antibodies specific towards gp 48 |
| 01/25/1990 | WO1990000614A1 Receptor specific proteins and their use in receptor typing |
| 01/25/1990 | WO1990000610A1 New expression vectors |
| 01/25/1990 | WO1990000609A1 Cellulose binding fusion proteins |
| 01/25/1990 | WO1990000607A2 Gap gene sequences and diagnostic uses thereof |
| 01/25/1990 | WO1990000606A1 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 01/25/1990 | WO1990000605A1 Methods and means for controlling the stability of proteins |
| 01/25/1990 | WO1990000604A1 Transformed shigella |
| 01/25/1990 | WO1990000600A1 A tissue plasminogen activator analogue |
| 01/25/1990 | WO1990000597A1 Post-transfusion, non-a, non-b hepatitis virus and antigens |
| 01/25/1990 | WO1990000594A2 Recombinant mycobacterial expression vehicles and uses therefor |
| 01/25/1990 | WO1990000569A1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
| 01/25/1990 | WO1990000568A1 A new polypeptide and a method for its production |
| 01/25/1990 | WO1990000567A1 A migration stimulating factor |
| 01/25/1990 | WO1990000566A1 Inhibition of hiv-1 infection with soluble cd4 |
| 01/25/1990 | WO1990000565A1 Interleukin ii analogs |
| 01/25/1990 | WO1990000564A1 Peptides with extraordinary opioid receptor selectivity |
| 01/25/1990 | WO1990000563A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
| 01/25/1990 | WO1990000562A1 Insulinomimetic and insulin receptor binding site peptides |
| 01/25/1990 | WO1990000561A1 Novel peptides |
| 01/25/1990 | WO1990000558A1 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
| 01/25/1990 | WO1990000405A1 Immunoconjugates for cancer diagnosis and therapy |
| 01/25/1990 | WO1990000403A1 Genetically engineered coccidiosis vaccine |
| 01/25/1990 | WO1990000402A1 Synthetic vaccine against p. falciparum malaria |
| 01/25/1990 | WO1990000400A1 Tumor necrosis enhancing factor and methods of preparation and use |
| 01/25/1990 | WO1990000399A1 Retroviral protease binding peptides |
| 01/25/1990 | WO1990000398A1 Method of preparing surface membrane antigens from human carcinoma cells |
| 01/24/1990 | EP0352250A2 Bordetella pertussis vaccine |
| 01/24/1990 | EP0352228A2 Novel proteins |
| 01/24/1990 | EP0352227A2 Modified proteins |
| 01/24/1990 | EP0352119A2 Vampire bat salivary plasminogen activators |
| 01/24/1990 | EP0352090A2 Method for preparation of nephritogenoside |
| 01/24/1990 | EP0352089A2 A modified human PSTI |
| 01/24/1990 | EP0352073A1 Vectors, cells transformed thereby, and their use in producing heterologous polypeptides |
| 01/24/1990 | EP0352060A2 Expression plasmid and use thereof |
| 01/24/1990 | EP0352052A2 Use of a gene product of a bacillus thuringiensis var. israelensis |
| 01/24/1990 | EP0352014A2 Cyclic GRF analogs |
| 01/24/1990 | EP0352000A2 Retroviral protease binding peptides |
| 01/24/1990 | EP0351944A1 Monoclonal antibodies to immunogenic human interleukin-3 peptide |
| 01/24/1990 | EP0351924A2 Improvements relating to transgenic plants |
| 01/24/1990 | EP0351921A2 Modified beta adrenergic receptor |
| 01/24/1990 | EP0351826A2 DNA encoding an anticoagulant polypeptide |
| 01/24/1990 | EP0351804A2 HCG peptides for use in antibody purification procedures |
| 01/24/1990 | EP0351685A2 Process for preparing n15-alkyl derivatives of teicoplanin compounds |
| 01/24/1990 | EP0351684A2 Process for preparing N15, N15-dialkyl derivatives of teicoplanin compounds |
| 01/24/1990 | EP0351604A1 Neisserial vaccines |
| 01/24/1990 | EP0351597A2 "N15-alkyl and N15,N15-di-alkyl derivatives of teicoplanin antibiotics carrying functional groups on the alkyl side chain |
| 01/24/1990 | EP0351586A1 Plasmids containing a chicken beta-actin promoter and a human factor VIII:C gene, transformants and processes for preparing human factor VIII:C |
| 01/24/1990 | EP0351585A2 Vector containing a chicken beta-actin gene promoter for the expression of a desired gene |
| 01/24/1990 | EP0351566A1 Protein curuculin and application of the same |
| 01/24/1990 | EP0351458A1 Process for preparing human alpha-foetoprotein |
| 01/24/1990 | EP0323959A4 PROTEINE PROTEASE INHIBITORS FROM -i(STREPTOMYCES). |
| 01/24/1990 | EP0148843B1 A concentrate of the antihemophilic factor viii and a process for producing it |